Mali vs Senegal: The number of people with susceptibility test result for rifampicin
Mali
26.76
in 2021
Senegal
30.79
in 2021
Mali rank
134th
Senegal rank
132nd
The number of people with susceptibility test result for rifampicin over time
- Mali
- Senegal
How they compare
Senegal currently reports 30.79 against 26.76 in Mali, a difference of 4.03.
That makes Senegal's figure about 1.2 times Mali's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Senegal ahead.
Mali ranks 134th and Senegal ranks 132nd of 146 countries.
Across the 2 decades both report, Mali averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Mali | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.3 | 24.99 | 21.68 | Senegal |
| 2020s | 40.18 | 23.63 | 16.55 | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mali or Senegal?
- Senegal, at 30.79 against 26.76 in Mali as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mali and Senegal?
- 4.03, with Senegal ahead.
- How many years of comparable data are there for Mali and Senegal?
- 5 years are reported by both, from 2017 to 2021.
- How do Mali and Senegal rank globally for the number of people with susceptibility test result for rifampicin?
- Mali ranks 134th and Senegal ranks 132nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.